PMC · DOI:10.1186/s12912-024-02078-6·June 17, 2024
Reply to Commentary to Skudlik et al. (2023): why a scoping review and why only Germany?
Stefanie Skudlik, Julian Hirt, Tobias Döringer, Regina Thalhammer, Katharina Lüftl, Martin Müller
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Species1
Diseases1
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHealth disparities and outcomes · Health Systems, Economic Evaluations, Quality of Life · Global Health Care Issues